Wasser Pain Management Centre, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada.
Cephalalgia. 2010 Jan;30(1):87-91. doi: 10.1111/j.1468-2982.2009.01900.x.
The aim was to examine pharmacological treatment of migraine patients admitted to a tertiary care pain clinic. A retrospective review of 100 consecutive migraine patients admitted to The Wasser Pain Management Centre was conducted. Patients included met the 2nd Edition of the International Classification of Headache Disorders criteria for diagnosis of migraine. Data were collected with regard to nicotine and alcohol consumption, family history of migraine headaches, other pain diagnoses and pharmacological treatment. Twenty-two per cent of these patients were male as opposed to 78% female. The mean age of patients admitted for migraine was 43.4 years. Of the patients admitted, 48% had tried at least one triptan in the past and only 31% were actively using triptan(s). The most commonly used triptan in the past had been sumatriptan, whereas the most common triptan used on admission was rizatriptan. Opiate use was much more prevalent; 72% of admitted patients were using an opiate and 27% used multiple opiates. A significant number of patients had not yet been tried on a triptan despite meeting the diagnostic criteria for migraine and having significant disability. More education of the general medical community may be beneficial in implementing a stratified care approach to migraine management.
目的在于研究在一家三级疼痛诊疗中心就诊的偏头痛患者的药物治疗情况。对 Water 疼痛管理中心收治的 100 例偏头痛患者进行了回顾性分析。这些患者符合偏头痛的第 2 版国际头痛疾病分类标准的诊断标准。收集的数据包括尼古丁和酒精的摄入情况、偏头痛家族史、其他疼痛诊断和药物治疗情况。这些患者中，22%为男性，78%为女性。偏头痛患者的平均年龄为 43.4 岁。在接受治疗的患者中，48%的患者过去至少尝试过一种曲坦类药物，只有 31%的患者正在积极使用曲坦类药物。过去最常用的曲坦类药物是舒马曲坦，而入院时最常用的曲坦类药物是利扎曲坦。阿片类药物的使用更为普遍；72%的入院患者正在使用阿片类药物，27%的患者使用多种阿片类药物。尽管符合偏头痛的诊断标准且存在明显的残疾，但仍有相当数量的患者尚未尝试使用曲坦类药物。对普通医疗社区进行更多的教育可能有助于实施偏头痛管理的分层护理方法。
